Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2092]

DNA nanorobots target HER2-positive breast cancer cells

DNA nanorobots target HER2-positive breast cancer cells

Early genome catastrophes can cause non-smoking lung cancer

Early genome catastrophes can cause non-smoking lung cancer

ASCO 2019: Novel targeted-antibody treatment produced responses in nearly half of patients with advanced urothelial cancer

ASCO 2019: Novel targeted-antibody treatment produced responses in nearly half of patients with advanced...

ASCO 2019: Colorectal cancer patients with liver metastases live just as long after laparoscopic surgery as open surgery

ASCO 2019: Colorectal cancer patients with liver metastases live just as long after laparoscopic surgery as open...

ASCO 2019: New blood test predicts breast cancer’s return at start of treatment

ASCO 2019: New blood test predicts breast cancer’s return at start of treatment

ASCO 2019: Drug targeting DNA damage response shows promise against cancers of anus and genitals

ASCO 2019: Drug targeting DNA damage response shows promise against cancers of anus and genitals

ASCO 2019: Pembrolizumab increases historic survival rate for certain people with advanced non-small cell lung cancer

ASCO 2019: Pembrolizumab increases historic survival rate for certain people with advanced non-small cell lung...

FDA approves alpelisib for metastatic breast cancer

FDA approves alpelisib for metastatic breast cancer

PSA, a prostate cancer marker, activates vascular and lymphangiogenic growth factors

PSA, a prostate cancer marker, activates vascular and lymphangiogenic growth factors

De-TOXing exhausted T cells may bolster CAR T immunotherapy against solid tumours

De-TOXing exhausted T cells may bolster CAR T immunotherapy against solid tumours

More from ecancer